NCT07056751

Brief Summary

To explore the effects of negative ions generated by an ion converter on the high-altitude acclimatization of healthy populations and their impact on serum HIF1 (hypoxia-inducible factor 1) and PWC170 index after entering high-altitude areas.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 22, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 9, 2025

Completed
Last Updated

July 15, 2025

Status Verified

July 1, 2025

Enrollment Period

2.4 years

First QC Date

June 22, 2025

Last Update Submit

July 13, 2025

Conditions

Keywords

Air negative ionsHigh-Altitude Adaptationhigh-altitude reactionsPWC170

Outcome Measures

Primary Outcomes (1)

  • High-Altitude Acclimatization

    Following their ascent to high altitudes, all participants completed the Acute Mountain Sickness (AMS) questionnaire daily, with AMS diagnosis based on the Lake Louise Criteria.

    two weeks

Secondary Outcomes (1)

  • PWC170 Index

    one day

Study Arms (2)

Air negative ion intervention study

EXPERIMENTAL

Arm 1: observation group (air negative ion intervention group) consisting of 30 individuals

Device: Air negative ion intervention study

No air negative ion intervention

PLACEBO COMPARATOR

Arm 2: control group (no air negative ion intervention group) consisting of 30 individuals

Device: No air negative ion intervention

Interventions

The observation group received air negative ion intervention every night for one week before entering the plateau (from 22:00 to 06:00). Before entering the plateau, they were in Putian City, China, where the temperature was about 28°C, humidity was about 68%, and the concentration of negative ions was approximately 800/cm³. The air negative ion converter used was the Mi Energy ET-21 model from RELTEC Medical Devices Corporation. Air negative and positive ion concentrations were measured using an ion detector (NKMH-103, HOKUTO, Japan) to ensure that each participant's room had a negative ion concentration of around 100,000/cm³.

Air negative ion intervention study

No air negative ion intervention

No air negative ion intervention

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy non-smoking men aged 18 or above and long-term residents of the plains no history of high-altitude exposure in the past 6 months no cardiovascular or pulmonary diseases not currently taking any medications.

You may not qualify if:

  • Tibetan ethnicity long-term residents of high altitudes history of high-altitude exposure in the past 6 months currently taking cold medicine, vitamins, corticosteroids, or other drugs presence of acute or chronic illnesses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ethics Committee of Putian 95 Hospital

Putian, Fujian, 351100, China

Location

MeSH Terms

Conditions

Altitude Sickness

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

June 22, 2025

First Posted

July 9, 2025

Study Start

May 1, 2022

Primary Completion

October 10, 2024

Study Completion

November 11, 2024

Last Updated

July 15, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL
Time Frame
07.01.2025-no end date
Access Criteria
Scientific researcher
More information

Locations